nodes	percent_of_prediction	percent_of_DWPC	metapath
Rifaximin—NR1I2—Docetaxel—skin cancer	0.454	0.583	CbGbCtD
Rifaximin—CYP3A4—Imiquimod—skin cancer	0.0946	0.122	CbGbCtD
Rifaximin—CYP3A4—Temozolomide—skin cancer	0.0946	0.122	CbGbCtD
Rifaximin—CYP3A4—Vismodegib—skin cancer	0.0656	0.0843	CbGbCtD
Rifaximin—CYP3A4—Vemurafenib—skin cancer	0.0518	0.0666	CbGbCtD
Rifaximin—CYP3A4—Docetaxel—skin cancer	0.0178	0.0229	CbGbCtD
Rifaximin—Depression—Temozolomide—skin cancer	0.00049	0.00221	CcSEcCtD
Rifaximin—Flushing—Bleomycin—skin cancer	0.000485	0.00219	CcSEcCtD
Rifaximin—Body temperature increased—Vemurafenib—skin cancer	0.000485	0.00219	CcSEcCtD
Rifaximin—Pharyngitis—Dactinomycin—skin cancer	0.000484	0.00218	CcSEcCtD
Rifaximin—Musculoskeletal discomfort—Imiquimod—skin cancer	0.000476	0.00215	CcSEcCtD
Rifaximin—Insomnia—Imiquimod—skin cancer	0.000473	0.00213	CcSEcCtD
Rifaximin—Upper respiratory tract infection—Fluorouracil—skin cancer	0.000472	0.00213	CcSEcCtD
Rifaximin—Dyspnoea—Imiquimod—skin cancer	0.000466	0.0021	CcSEcCtD
Rifaximin—Photosensitivity reaction—Fluorouracil—skin cancer	0.000463	0.00209	CcSEcCtD
Rifaximin—Pneumonia—Fluorouracil—skin cancer	0.000455	0.00205	CcSEcCtD
Rifaximin—Decreased appetite—Imiquimod—skin cancer	0.000454	0.00205	CcSEcCtD
Rifaximin—Hot flush—Docetaxel—skin cancer	0.000453	0.00204	CcSEcCtD
Rifaximin—Infestation NOS—Fluorouracil—skin cancer	0.000453	0.00204	CcSEcCtD
Rifaximin—Infestation—Fluorouracil—skin cancer	0.000453	0.00204	CcSEcCtD
Rifaximin—Flushing—Dactinomycin—skin cancer	0.000452	0.00204	CcSEcCtD
Rifaximin—Hypersensitivity—Vemurafenib—skin cancer	0.000452	0.00204	CcSEcCtD
Rifaximin—Gastrointestinal disorder—Imiquimod—skin cancer	0.000451	0.00204	CcSEcCtD
Rifaximin—Fatigue—Imiquimod—skin cancer	0.000451	0.00203	CcSEcCtD
Rifaximin—Menopausal symptoms—Docetaxel—skin cancer	0.000449	0.00203	CcSEcCtD
Rifaximin—Pain—Imiquimod—skin cancer	0.000447	0.00202	CcSEcCtD
Rifaximin—Haemoglobin—Temozolomide—skin cancer	0.000443	0.002	CcSEcCtD
Rifaximin—Haemorrhage—Temozolomide—skin cancer	0.000441	0.00199	CcSEcCtD
Rifaximin—Asthenia—Vemurafenib—skin cancer	0.00044	0.00198	CcSEcCtD
Rifaximin—Hypoaesthesia—Temozolomide—skin cancer	0.000439	0.00198	CcSEcCtD
Rifaximin—Pharyngitis—Temozolomide—skin cancer	0.000438	0.00197	CcSEcCtD
Rifaximin—Urinary tract disorder—Temozolomide—skin cancer	0.000435	0.00196	CcSEcCtD
Rifaximin—Oedema peripheral—Temozolomide—skin cancer	0.000434	0.00196	CcSEcCtD
Rifaximin—Pruritus—Vemurafenib—skin cancer	0.000434	0.00196	CcSEcCtD
Rifaximin—Urethral disorder—Temozolomide—skin cancer	0.000432	0.00195	CcSEcCtD
Rifaximin—Feeling abnormal—Imiquimod—skin cancer	0.000431	0.00194	CcSEcCtD
Rifaximin—Gastrointestinal pain—Imiquimod—skin cancer	0.000427	0.00193	CcSEcCtD
Rifaximin—Epistaxis—Fluorouracil—skin cancer	0.000427	0.00193	CcSEcCtD
Rifaximin—Hyponatraemia—Docetaxel—skin cancer	0.000426	0.00192	CcSEcCtD
Rifaximin—Pain in extremity—Docetaxel—skin cancer	0.000424	0.00191	CcSEcCtD
Rifaximin—Ill-defined disorder—Bleomycin—skin cancer	0.000422	0.0019	CcSEcCtD
Rifaximin—Anaemia—Bleomycin—skin cancer	0.000421	0.0019	CcSEcCtD
Rifaximin—Diarrhoea—Vemurafenib—skin cancer	0.000419	0.00189	CcSEcCtD
Rifaximin—Migraine—Docetaxel—skin cancer	0.000417	0.00188	CcSEcCtD
Rifaximin—Urticaria—Imiquimod—skin cancer	0.000415	0.00187	CcSEcCtD
Rifaximin—Body temperature increased—Imiquimod—skin cancer	0.000413	0.00186	CcSEcCtD
Rifaximin—Abdominal pain—Imiquimod—skin cancer	0.000413	0.00186	CcSEcCtD
Rifaximin—Tinnitus—Temozolomide—skin cancer	0.000411	0.00185	CcSEcCtD
Rifaximin—Malaise—Bleomycin—skin cancer	0.00041	0.00185	CcSEcCtD
Rifaximin—Flushing—Temozolomide—skin cancer	0.000409	0.00185	CcSEcCtD
Rifaximin—Haemoglobin—Fluorouracil—skin cancer	0.000408	0.00184	CcSEcCtD
Rifaximin—Rhinitis—Fluorouracil—skin cancer	0.000407	0.00184	CcSEcCtD
Rifaximin—Haemorrhage—Fluorouracil—skin cancer	0.000406	0.00183	CcSEcCtD
Rifaximin—Dizziness—Vemurafenib—skin cancer	0.000405	0.00183	CcSEcCtD
Rifaximin—Hypoaesthesia—Fluorouracil—skin cancer	0.000404	0.00182	CcSEcCtD
Rifaximin—Pharyngitis—Fluorouracil—skin cancer	0.000403	0.00182	CcSEcCtD
Rifaximin—Angiopathy—Temozolomide—skin cancer	0.0004	0.0018	CcSEcCtD
Rifaximin—Mediastinal disorder—Temozolomide—skin cancer	0.000397	0.00179	CcSEcCtD
Rifaximin—Cough—Bleomycin—skin cancer	0.000397	0.00179	CcSEcCtD
Rifaximin—Dehydration—Docetaxel—skin cancer	0.000394	0.00178	CcSEcCtD
Rifaximin—Ill-defined disorder—Dactinomycin—skin cancer	0.000394	0.00178	CcSEcCtD
Rifaximin—Anaemia—Dactinomycin—skin cancer	0.000392	0.00177	CcSEcCtD
Rifaximin—Vomiting—Vemurafenib—skin cancer	0.00039	0.00176	CcSEcCtD
Rifaximin—Chest pain—Bleomycin—skin cancer	0.000387	0.00175	CcSEcCtD
Rifaximin—Myalgia—Bleomycin—skin cancer	0.000387	0.00175	CcSEcCtD
Rifaximin—Abdominal pain upper—Docetaxel—skin cancer	0.000387	0.00175	CcSEcCtD
Rifaximin—Rash—Vemurafenib—skin cancer	0.000386	0.00174	CcSEcCtD
Rifaximin—Mental disorder—Temozolomide—skin cancer	0.000386	0.00174	CcSEcCtD
Rifaximin—Dermatitis—Vemurafenib—skin cancer	0.000386	0.00174	CcSEcCtD
Rifaximin—Hypersensitivity—Imiquimod—skin cancer	0.000385	0.00174	CcSEcCtD
Rifaximin—Headache—Vemurafenib—skin cancer	0.000384	0.00173	CcSEcCtD
Rifaximin—Malnutrition—Temozolomide—skin cancer	0.000384	0.00173	CcSEcCtD
Rifaximin—Discomfort—Bleomycin—skin cancer	0.000383	0.00173	CcSEcCtD
Rifaximin—Malaise—Dactinomycin—skin cancer	0.000383	0.00173	CcSEcCtD
Rifaximin—Aspartate aminotransferase increased—Docetaxel—skin cancer	0.000382	0.00172	CcSEcCtD
Rifaximin—Nasopharyngitis—Docetaxel—skin cancer	0.000379	0.00171	CcSEcCtD
Rifaximin—Asthenia—Imiquimod—skin cancer	0.000375	0.00169	CcSEcCtD
Rifaximin—Confusional state—Bleomycin—skin cancer	0.000374	0.00169	CcSEcCtD
Rifaximin—Anaphylactic shock—Bleomycin—skin cancer	0.000371	0.00167	CcSEcCtD
Rifaximin—Back pain—Temozolomide—skin cancer	0.000371	0.00167	CcSEcCtD
Rifaximin—Pruritus—Imiquimod—skin cancer	0.00037	0.00167	CcSEcCtD
Rifaximin—Infection—Bleomycin—skin cancer	0.000369	0.00166	CcSEcCtD
Rifaximin—Dysphagia—Docetaxel—skin cancer	0.000366	0.00165	CcSEcCtD
Rifaximin—Nausea—Vemurafenib—skin cancer	0.000364	0.00164	CcSEcCtD
Rifaximin—Myalgia—Dactinomycin—skin cancer	0.000361	0.00163	CcSEcCtD
Rifaximin—Tremor—Temozolomide—skin cancer	0.00036	0.00162	CcSEcCtD
Rifaximin—Diarrhoea—Imiquimod—skin cancer	0.000358	0.00161	CcSEcCtD
Rifaximin—Discomfort—Dactinomycin—skin cancer	0.000357	0.00161	CcSEcCtD
Rifaximin—Ill-defined disorder—Temozolomide—skin cancer	0.000356	0.00161	CcSEcCtD
Rifaximin—Anaemia—Temozolomide—skin cancer	0.000355	0.0016	CcSEcCtD
Rifaximin—Anorexia—Bleomycin—skin cancer	0.000354	0.0016	CcSEcCtD
Rifaximin—Angioedema—Temozolomide—skin cancer	0.000351	0.00158	CcSEcCtD
Rifaximin—Hypotension—Bleomycin—skin cancer	0.000347	0.00156	CcSEcCtD
Rifaximin—Malaise—Temozolomide—skin cancer	0.000346	0.00156	CcSEcCtD
Rifaximin—Dizziness—Imiquimod—skin cancer	0.000346	0.00156	CcSEcCtD
Rifaximin—Vertigo—Temozolomide—skin cancer	0.000345	0.00156	CcSEcCtD
Rifaximin—Infection—Dactinomycin—skin cancer	0.000344	0.00155	CcSEcCtD
Rifaximin—Neutropenia—Docetaxel—skin cancer	0.000343	0.00154	CcSEcCtD
Rifaximin—Musculoskeletal discomfort—Bleomycin—skin cancer	0.000338	0.00153	CcSEcCtD
Rifaximin—Cough—Temozolomide—skin cancer	0.000335	0.00151	CcSEcCtD
Rifaximin—Weight increased—Docetaxel—skin cancer	0.000333	0.0015	CcSEcCtD
Rifaximin—Vomiting—Imiquimod—skin cancer	0.000332	0.0015	CcSEcCtD
Rifaximin—Weight decreased—Docetaxel—skin cancer	0.000331	0.00149	CcSEcCtD
Rifaximin—Dyspnoea—Bleomycin—skin cancer	0.000331	0.00149	CcSEcCtD
Rifaximin—Anorexia—Dactinomycin—skin cancer	0.00033	0.00149	CcSEcCtD
Rifaximin—Rash—Imiquimod—skin cancer	0.00033	0.00149	CcSEcCtD
Rifaximin—Dermatitis—Imiquimod—skin cancer	0.000329	0.00149	CcSEcCtD
Rifaximin—Pneumonia—Docetaxel—skin cancer	0.000329	0.00148	CcSEcCtD
Rifaximin—Headache—Imiquimod—skin cancer	0.000327	0.00148	CcSEcCtD
Rifaximin—Anaemia—Fluorouracil—skin cancer	0.000327	0.00147	CcSEcCtD
Rifaximin—Myalgia—Temozolomide—skin cancer	0.000327	0.00147	CcSEcCtD
Rifaximin—Arthralgia—Temozolomide—skin cancer	0.000327	0.00147	CcSEcCtD
Rifaximin—Infestation—Docetaxel—skin cancer	0.000327	0.00147	CcSEcCtD
Rifaximin—Infestation NOS—Docetaxel—skin cancer	0.000327	0.00147	CcSEcCtD
Rifaximin—Unspecified disorder of skin and subcutaneous tissue—Temozolomide—skin cancer	0.000324	0.00146	CcSEcCtD
Rifaximin—Discomfort—Temozolomide—skin cancer	0.000323	0.00146	CcSEcCtD
Rifaximin—Decreased appetite—Bleomycin—skin cancer	0.000323	0.00146	CcSEcCtD
Rifaximin—Dry mouth—Temozolomide—skin cancer	0.00032	0.00144	CcSEcCtD
Rifaximin—Pain—Bleomycin—skin cancer	0.000318	0.00143	CcSEcCtD
Rifaximin—Confusional state—Temozolomide—skin cancer	0.000316	0.00142	CcSEcCtD
Rifaximin—Musculoskeletal discomfort—Dactinomycin—skin cancer	0.000316	0.00142	CcSEcCtD
Rifaximin—Anaphylactic shock—Temozolomide—skin cancer	0.000313	0.00141	CcSEcCtD
Rifaximin—Infection—Temozolomide—skin cancer	0.000311	0.0014	CcSEcCtD
Rifaximin—Nausea—Imiquimod—skin cancer	0.00031	0.0014	CcSEcCtD
Rifaximin—Epistaxis—Docetaxel—skin cancer	0.000308	0.00139	CcSEcCtD
Rifaximin—Nervous system disorder—Temozolomide—skin cancer	0.000307	0.00139	CcSEcCtD
Rifaximin—Feeling abnormal—Bleomycin—skin cancer	0.000306	0.00138	CcSEcCtD
Rifaximin—Skin disorder—Temozolomide—skin cancer	0.000304	0.00137	CcSEcCtD
Rifaximin—Hyperhidrosis—Temozolomide—skin cancer	0.000303	0.00137	CcSEcCtD
Rifaximin—Myalgia—Fluorouracil—skin cancer	0.000301	0.00136	CcSEcCtD
Rifaximin—Chest pain—Fluorouracil—skin cancer	0.000301	0.00136	CcSEcCtD
Rifaximin—Decreased appetite—Dactinomycin—skin cancer	0.000301	0.00136	CcSEcCtD
Rifaximin—Fatigue—Dactinomycin—skin cancer	0.000299	0.00135	CcSEcCtD
Rifaximin—Anorexia—Temozolomide—skin cancer	0.000299	0.00135	CcSEcCtD
Rifaximin—Discomfort—Fluorouracil—skin cancer	0.000297	0.00134	CcSEcCtD
Rifaximin—Pain—Dactinomycin—skin cancer	0.000296	0.00134	CcSEcCtD
Rifaximin—Urticaria—Bleomycin—skin cancer	0.000295	0.00133	CcSEcCtD
Rifaximin—Haemoglobin—Docetaxel—skin cancer	0.000295	0.00133	CcSEcCtD
Rifaximin—Rhinitis—Docetaxel—skin cancer	0.000294	0.00133	CcSEcCtD
Rifaximin—Body temperature increased—Bleomycin—skin cancer	0.000294	0.00132	CcSEcCtD
Rifaximin—Haemorrhage—Docetaxel—skin cancer	0.000293	0.00132	CcSEcCtD
Rifaximin—Hypoaesthesia—Docetaxel—skin cancer	0.000292	0.00132	CcSEcCtD
Rifaximin—Confusional state—Fluorouracil—skin cancer	0.000291	0.00131	CcSEcCtD
Rifaximin—Pharyngitis—Docetaxel—skin cancer	0.000291	0.00131	CcSEcCtD
Rifaximin—Urinary tract disorder—Docetaxel—skin cancer	0.00029	0.00131	CcSEcCtD
Rifaximin—Oedema peripheral—Docetaxel—skin cancer	0.000289	0.0013	CcSEcCtD
Rifaximin—Anaphylactic shock—Fluorouracil—skin cancer	0.000289	0.0013	CcSEcCtD
Rifaximin—Urethral disorder—Docetaxel—skin cancer	0.000287	0.0013	CcSEcCtD
Rifaximin—Infection—Fluorouracil—skin cancer	0.000287	0.00129	CcSEcCtD
Rifaximin—Feeling abnormal—Dactinomycin—skin cancer	0.000285	0.00129	CcSEcCtD
Rifaximin—Musculoskeletal discomfort—Temozolomide—skin cancer	0.000285	0.00129	CcSEcCtD
Rifaximin—Insomnia—Temozolomide—skin cancer	0.000283	0.00128	CcSEcCtD
Rifaximin—Gastrointestinal pain—Dactinomycin—skin cancer	0.000283	0.00128	CcSEcCtD
Rifaximin—Nervous system disorder—Fluorouracil—skin cancer	0.000283	0.00128	CcSEcCtD
Rifaximin—Dyspnoea—Temozolomide—skin cancer	0.000279	0.00126	CcSEcCtD
Rifaximin—Anorexia—Fluorouracil—skin cancer	0.000275	0.00124	CcSEcCtD
Rifaximin—Abdominal pain—Dactinomycin—skin cancer	0.000274	0.00123	CcSEcCtD
Rifaximin—Body temperature increased—Dactinomycin—skin cancer	0.000274	0.00123	CcSEcCtD
Rifaximin—Hypersensitivity—Bleomycin—skin cancer	0.000274	0.00123	CcSEcCtD
Rifaximin—Decreased appetite—Temozolomide—skin cancer	0.000272	0.00123	CcSEcCtD
Rifaximin—Flushing—Docetaxel—skin cancer	0.000272	0.00123	CcSEcCtD
Rifaximin—Gastrointestinal disorder—Temozolomide—skin cancer	0.00027	0.00122	CcSEcCtD
Rifaximin—Fatigue—Temozolomide—skin cancer	0.00027	0.00122	CcSEcCtD
Rifaximin—Hypotension—Fluorouracil—skin cancer	0.00027	0.00122	CcSEcCtD
Rifaximin—Pain—Temozolomide—skin cancer	0.000268	0.00121	CcSEcCtD
Rifaximin—Constipation—Temozolomide—skin cancer	0.000268	0.00121	CcSEcCtD
Rifaximin—Asthenia—Bleomycin—skin cancer	0.000266	0.0012	CcSEcCtD
Rifaximin—Angiopathy—Docetaxel—skin cancer	0.000266	0.0012	CcSEcCtD
Rifaximin—Mediastinal disorder—Docetaxel—skin cancer	0.000264	0.00119	CcSEcCtD
Rifaximin—Musculoskeletal discomfort—Fluorouracil—skin cancer	0.000263	0.00119	CcSEcCtD
Rifaximin—Pruritus—Bleomycin—skin cancer	0.000263	0.00118	CcSEcCtD
Rifaximin—Insomnia—Fluorouracil—skin cancer	0.000261	0.00118	CcSEcCtD
Rifaximin—Feeling abnormal—Temozolomide—skin cancer	0.000258	0.00116	CcSEcCtD
Rifaximin—Dyspnoea—Fluorouracil—skin cancer	0.000257	0.00116	CcSEcCtD
Rifaximin—Mental disorder—Docetaxel—skin cancer	0.000257	0.00116	CcSEcCtD
Rifaximin—Gastrointestinal pain—Temozolomide—skin cancer	0.000256	0.00116	CcSEcCtD
Rifaximin—Malnutrition—Docetaxel—skin cancer	0.000255	0.00115	CcSEcCtD
Rifaximin—Hypersensitivity—Dactinomycin—skin cancer	0.000255	0.00115	CcSEcCtD
Rifaximin—Decreased appetite—Fluorouracil—skin cancer	0.000251	0.00113	CcSEcCtD
Rifaximin—Gastrointestinal disorder—Fluorouracil—skin cancer	0.000249	0.00112	CcSEcCtD
Rifaximin—Urticaria—Temozolomide—skin cancer	0.000249	0.00112	CcSEcCtD
Rifaximin—Asthenia—Dactinomycin—skin cancer	0.000248	0.00112	CcSEcCtD
Rifaximin—Abdominal pain—Temozolomide—skin cancer	0.000248	0.00112	CcSEcCtD
Rifaximin—Body temperature increased—Temozolomide—skin cancer	0.000248	0.00112	CcSEcCtD
Rifaximin—Back pain—Docetaxel—skin cancer	0.000247	0.00111	CcSEcCtD
Rifaximin—Pain—Fluorouracil—skin cancer	0.000247	0.00111	CcSEcCtD
Rifaximin—Muscle spasms—Docetaxel—skin cancer	0.000245	0.00111	CcSEcCtD
Rifaximin—Feeling abnormal—Fluorouracil—skin cancer	0.000238	0.00107	CcSEcCtD
Rifaximin—Diarrhoea—Dactinomycin—skin cancer	0.000237	0.00107	CcSEcCtD
Rifaximin—Vomiting—Bleomycin—skin cancer	0.000236	0.00106	CcSEcCtD
Rifaximin—Anaemia—Docetaxel—skin cancer	0.000236	0.00106	CcSEcCtD
Rifaximin—Rash—Bleomycin—skin cancer	0.000234	0.00106	CcSEcCtD
Rifaximin—Dermatitis—Bleomycin—skin cancer	0.000234	0.00106	CcSEcCtD
Rifaximin—Hypersensitivity—Temozolomide—skin cancer	0.000231	0.00104	CcSEcCtD
Rifaximin—Urticaria—Fluorouracil—skin cancer	0.000229	0.00103	CcSEcCtD
Rifaximin—Syncope—Docetaxel—skin cancer	0.000229	0.00103	CcSEcCtD
Rifaximin—Body temperature increased—Fluorouracil—skin cancer	0.000228	0.00103	CcSEcCtD
Rifaximin—Asthenia—Temozolomide—skin cancer	0.000225	0.00101	CcSEcCtD
Rifaximin—Loss of consciousness—Docetaxel—skin cancer	0.000224	0.00101	CcSEcCtD
Rifaximin—Cough—Docetaxel—skin cancer	0.000223	0.001	CcSEcCtD
Rifaximin—Pruritus—Temozolomide—skin cancer	0.000222	0.001	CcSEcCtD
Rifaximin—Nausea—Bleomycin—skin cancer	0.000221	0.000995	CcSEcCtD
Rifaximin—Vomiting—Dactinomycin—skin cancer	0.00022	0.000993	CcSEcCtD
Rifaximin—Rash—Dactinomycin—skin cancer	0.000218	0.000985	CcSEcCtD
Rifaximin—Myalgia—Docetaxel—skin cancer	0.000217	0.00098	CcSEcCtD
Rifaximin—Chest pain—Docetaxel—skin cancer	0.000217	0.00098	CcSEcCtD
Rifaximin—Arthralgia—Docetaxel—skin cancer	0.000217	0.00098	CcSEcCtD
Rifaximin—Unspecified disorder of skin and subcutaneous tissue—Docetaxel—skin cancer	0.000216	0.000973	CcSEcCtD
Rifaximin—Diarrhoea—Temozolomide—skin cancer	0.000214	0.000967	CcSEcCtD
Rifaximin—Hypersensitivity—Fluorouracil—skin cancer	0.000213	0.000959	CcSEcCtD
Rifaximin—Dry mouth—Docetaxel—skin cancer	0.000213	0.000958	CcSEcCtD
Rifaximin—Confusional state—Docetaxel—skin cancer	0.00021	0.000947	CcSEcCtD
Rifaximin—Anaphylactic shock—Docetaxel—skin cancer	0.000208	0.00094	CcSEcCtD
Rifaximin—Dizziness—Temozolomide—skin cancer	0.000207	0.000934	CcSEcCtD
Rifaximin—Infection—Docetaxel—skin cancer	0.000207	0.000933	CcSEcCtD
Rifaximin—Nausea—Dactinomycin—skin cancer	0.000206	0.000928	CcSEcCtD
Rifaximin—Shock—Docetaxel—skin cancer	0.000205	0.000924	CcSEcCtD
Rifaximin—Nervous system disorder—Docetaxel—skin cancer	0.000204	0.000921	CcSEcCtD
Rifaximin—Pruritus—Fluorouracil—skin cancer	0.000204	0.000921	CcSEcCtD
Rifaximin—Skin disorder—Docetaxel—skin cancer	0.000202	0.000913	CcSEcCtD
Rifaximin—Vomiting—Temozolomide—skin cancer	0.000199	0.000898	CcSEcCtD
Rifaximin—Anorexia—Docetaxel—skin cancer	0.000199	0.000896	CcSEcCtD
Rifaximin—Rash—Temozolomide—skin cancer	0.000197	0.000891	CcSEcCtD
Rifaximin—Diarrhoea—Fluorouracil—skin cancer	0.000197	0.000891	CcSEcCtD
Rifaximin—Dermatitis—Temozolomide—skin cancer	0.000197	0.00089	CcSEcCtD
Rifaximin—Headache—Temozolomide—skin cancer	0.000196	0.000885	CcSEcCtD
Rifaximin—Hypotension—Docetaxel—skin cancer	0.000195	0.000878	CcSEcCtD
Rifaximin—Dizziness—Fluorouracil—skin cancer	0.000191	0.000861	CcSEcCtD
Rifaximin—Musculoskeletal discomfort—Docetaxel—skin cancer	0.00019	0.000856	CcSEcCtD
Rifaximin—Insomnia—Docetaxel—skin cancer	0.000188	0.00085	CcSEcCtD
Rifaximin—Nausea—Temozolomide—skin cancer	0.000186	0.000839	CcSEcCtD
Rifaximin—Dyspnoea—Docetaxel—skin cancer	0.000186	0.000838	CcSEcCtD
Rifaximin—Vomiting—Fluorouracil—skin cancer	0.000183	0.000828	CcSEcCtD
Rifaximin—Rash—Fluorouracil—skin cancer	0.000182	0.000821	CcSEcCtD
Rifaximin—Dermatitis—Fluorouracil—skin cancer	0.000182	0.00082	CcSEcCtD
Rifaximin—Decreased appetite—Docetaxel—skin cancer	0.000181	0.000817	CcSEcCtD
Rifaximin—Headache—Fluorouracil—skin cancer	0.000181	0.000815	CcSEcCtD
Rifaximin—Gastrointestinal disorder—Docetaxel—skin cancer	0.00018	0.000811	CcSEcCtD
Rifaximin—Fatigue—Docetaxel—skin cancer	0.00018	0.00081	CcSEcCtD
Rifaximin—Constipation—Docetaxel—skin cancer	0.000178	0.000803	CcSEcCtD
Rifaximin—Pain—Docetaxel—skin cancer	0.000178	0.000803	CcSEcCtD
Rifaximin—Feeling abnormal—Docetaxel—skin cancer	0.000172	0.000774	CcSEcCtD
Rifaximin—Nausea—Fluorouracil—skin cancer	0.000171	0.000773	CcSEcCtD
Rifaximin—Gastrointestinal pain—Docetaxel—skin cancer	0.00017	0.000768	CcSEcCtD
Rifaximin—Abdominal pain—Docetaxel—skin cancer	0.000165	0.000743	CcSEcCtD
Rifaximin—Body temperature increased—Docetaxel—skin cancer	0.000165	0.000743	CcSEcCtD
Rifaximin—Hypersensitivity—Docetaxel—skin cancer	0.000153	0.000692	CcSEcCtD
Rifaximin—Asthenia—Docetaxel—skin cancer	0.000149	0.000674	CcSEcCtD
Rifaximin—Pruritus—Docetaxel—skin cancer	0.000147	0.000665	CcSEcCtD
Rifaximin—Diarrhoea—Docetaxel—skin cancer	0.000143	0.000643	CcSEcCtD
Rifaximin—Dizziness—Docetaxel—skin cancer	0.000138	0.000621	CcSEcCtD
Rifaximin—Vomiting—Docetaxel—skin cancer	0.000132	0.000597	CcSEcCtD
Rifaximin—Rash—Docetaxel—skin cancer	0.000131	0.000592	CcSEcCtD
Rifaximin—Dermatitis—Docetaxel—skin cancer	0.000131	0.000592	CcSEcCtD
Rifaximin—Headache—Docetaxel—skin cancer	0.00013	0.000589	CcSEcCtD
Rifaximin—Nausea—Docetaxel—skin cancer	0.000124	0.000558	CcSEcCtD
